对治疗多发性硬化症的治愈性基因疗法的早期健康技术评估
Attila Imre1,2, Balázs Nagy1,2,3, Rok Hren3,4,5
1Center for Health Technology Assessment, Semmelweis University, Budapest, Hungary.
British journal of clinical pharmacology
|August 18, 2025
概括
这项研究表明,IMMUTOL基因治疗对于多发性硬化症 (MS) 是具有成本效益的. 它比当前的治疗方法提供了更好的结果和更低的成本,基于价值的价格高达50万欧元.
科学领域:
- 卫生经济学 卫生经济学
- 基因治疗 基因治疗
- 神经学 神经学
背景情况:
- 多发性硬化症 (MS) 具有显著的早期发病率,预期寿命缩短,以及大量的医疗保健费用.
- 目前对MS的高效疗法涉及复杂的序列和持续的管理.
- 评估像基因疗法这样的新型治疗策略对于改善患者的治疗结果和管理疾病负担至关重要.
研究的目的:
- 与现有的高效治疗序列相比,评估IMMUTOL基因治疗MS的早期成本效益.
- 根据荷兰卫生经济指南,确定IMMUTOL基因疗法的基于价值的定价门.
主要方法:
- 使用ErasmusMC/iMTA MS微仿真模型进行终身地平线分析.
- 从社会和医疗保健的角度比较IMMUTOL基因疗法与各种疾病修饰疗法序列.
- 整合了概率敏感性分析,以解决IMMUTOL的不确定性和多样化的疗效/不良事件参数.
主要成果:
- 在高达20万欧元的价格上,IMMUTOL基因疗法证明了成本效益主导地位.
- 在现实的临床场景下 (ICER €26,570-€40,615/QALY),成本效益保持在50万欧元.
- 社会间接成本提高了基因疗法的经济吸引力,其门取决于持续的疗效 (IRR ≤0.2,RR ≤0.1).
结论:
- 基因疗法IMMUTOL为MS提供了有希望的成本效益,以价值为基础的价格高达50万欧元,只要实现治愈性临床疗效.
- 这些发现支持在MS领域新兴基因疗法的战略开发和定价考虑.
- 这项研究强调了基因疗法的潜力,改变了MS管理的经济范式.
相关概念视频
00:59Gene Therapy
25.8K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.8K
01:29Microorganisms in Medicine and Therapeutics
314
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
314
01:22iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
01:21Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K